An experimental drug stops advanced breast cancer from progressing in some people with tumors that have grown resistant to ...
A groundbreaking international study has found that imlunestrant plus abemaciclib significantly improved progression-free survival (PFS) versus imlunestrant monotherapy in patients with estrogen ...
Tea will be served at 12:45 p.m., immediately preceding the seminar.
We apply both precision gene editing and large-scale CRISPR screening in human pluripotent stem cells (hPSCs) to explore mechanisms underlying human development. Specifically, we are interrogating the ...
Research at MSK Our research impact Research topics Core facilities & resources ...
Research at MSK Our research impact Research topics Core facilities & resources ...
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
Tea will be served at 12:45 p.m., immediately preceding the seminar.
Research at MSK Our research impact Research topics Core facilities & resources ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback